Alexei
Verkhratsky
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoGlaxoSmithKline (United Kingdom)-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2007
-
Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progression
Journal of Neurochemistry, Vol. 103, Núm. 3, pp. 1132-1144